Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Egetis Therapeutics

5.80 SEK

+0.52 %

Less than 1K followers

EGTX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Egetis Therapeutics

EV/S

Median 2019-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)18.086.856.167.105.587.005.34
Shares57.173.4179.9214.6292.6359.2395.2
Market cap1,032.5503.41,107.61,523.61,632.52,514.72,110.2
Enterprise value777.4215.6963.61,395.91,437.82,277.9-
EV/S9.45.342.761.825.049.4-
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B4.220.802.103.012.995.106.23
P/S12.512.449.067.428.354.533.8
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio90.7 %70.4 %92.6 %90.2 %71.8 %62.2 %53.0 %
Gearing ratio----19.9 %23.2 %24.2 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.